Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Mireia Casanovas, Mireia Jiménez‐Rosés, Arnau Cordomí, Alejandro Lillo, Ignacio Vega‐Quiroga, Joan Izquierdo, Mireia Medrano, Katia Gysling, Leonardo Pardo, Gemma Navarro & Rafael Franco. (2021) Discovery of a macromolecular complex mediating the hunger suppressive actions of cocaine: Structural and functional properties. Addiction Biology 26:5.
Crossref
Crossref
David R. Wallace, Yasmeen M. Taalab, Sarah Heinze, Blanka Tariba Lovaković, Alica Pizent, Elisavet Renieri, Aristidis Tsatsakis, Ammad Ahmad Farooqi, Dragana Javorac, Milena Andjelkovic, Zorica Bulat, Biljana Antonijević & Aleksandra Buha Djordjevic. (2020) Toxic-Metal-Induced Alteration in miRNA Expression Profile as a Proposed Mechanism for Disease Development. Cells 9:4, pages 901.
Crossref
Crossref
Xiaoqin Huang, Howard H. Gu & Chang-Guo Zhan. (2009) Mechanism for Cocaine Blocking the Transport of Dopamine: Insights from Molecular Modeling and Dynamics Simulations. The Journal of Physical Chemistry B 113:45, pages 15057-15066.
Crossref
Crossref
Trent J. Volz & James O. Schenk. (2005) A comprehensive atlas of the topography of functional groups of the dopamine transporter. Synapse 58:2, pages 72-94.
Crossref
Crossref
Trent J. Volz & James O. Schenk. (2004) L‐arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase‐dependent mechanism. Synapse 54:3, pages 173-182.
Crossref
Crossref
Trent J. Volz, M. Kim & James O. Schenk. (2004) Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity. Synapse 52:4, pages 272-282.
Crossref
Crossref
Jean-Jacques Bonnet. (2003) Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter. European Journal of Pharmacology 479:1-3, pages 199-212.
Crossref
Crossref
Phillip G. Greco & Paul A. Garris. (2003) In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry. European Journal of Pharmacology 479:1-3, pages 117-125.
Crossref
Crossref
Peter C. Meltzer, Shanghao Liu, Heather S. Blanchette, Paul Blundell & Bertha K. Madras. (2002) Design and synthesis of an irreversible dopamine-sparing cocaine antagonist. Bioorganic & Medicinal Chemistry 10:11, pages 3583-3591.
Crossref
Crossref
Nikolaus Seiler, Benoit Duranton, Francis Raul, Zhi Hong, Craig E. Cameron, Jie Hong Hu, Charles Krieger, James O. Schenk, Laszlo Prokai, David F. Horrobin, Suprabhat Ray, Reema Rastogi & Atul KumarJames O. Schenk. 2002. Progress in Drug Research. Progress in Drug Research
111
131
.
Qun Wu, Maarten E.A. Reith, R.Mark Wightman, Kirk T. Kawagoe & Paul A. Garris. (2001) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. Journal of Neuroscience Methods 112:2, pages 119-133.
Crossref
Crossref
Rachel E. Whitehead, Jasmine V. Ferrer, Jonathan A. Javitch & Joseph B. Justice. (2001) Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. Journal of Neurochemistry 76:4, pages 1242-1251.
Crossref
Crossref
Nianhang Chen, Jasmine V. Ferrer, Jonathan A. Javitch & Joseph B. JusticeJr.Jr.. (2000) Transport-dependent Accessibility of a Cytoplasmic Loop Cysteine in the Human Dopamine Transporter. Journal of Biological Chemistry 275:3, pages 1608-1614.
Crossref
Crossref
P. Fleuranceau-Morel, L. Barrier, B. Fauconneau, A. Piriou & F. Huguet. (1999) Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes. Neuroscience Letters 277:2, pages 91-94.
Crossref
Crossref
Cynthia Earles & James O. Schenk. (1999) Multisubtrate mechanism for the inward transport of dopamine by the human dopamine transporter expressed in HEK cells and its inhibition by cocaine. Synapse 33:3, pages 230-238.
Crossref
Crossref
Heather M Haughey, Jeffrey M Brown, Annette E Fleckenstein & Glen R Hanson. (1999) Oxygen radicals differentially affect Na+/Cl−-dependent transporters. European Journal of Pharmacology 379:1, pages 107-110.
Crossref
Crossref
P Morel, C Tallineau, R Pontcharraud, A Piriou & F Huguet. (1998) Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes. Neurochemistry International 33:6, pages 531-540.
Crossref
Crossref
Patricia Morel, Bernard Fauconneau, Guylène Page, Thierry Mirbeau & François Huguet. (1998) Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Neuroscience Research 32:2, pages 171-179.
Crossref
Crossref
Jasmine V. Ferrer & Jonathan A. Javitch. (1998) Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proceedings of the National Academy of Sciences 95:16, pages 9238-9243.
Crossref
Crossref
Jonathan A. Javitch. 1998. Neurotransmitter Transporters. Neurotransmitter Transporters
331
346
.
Amadou T. Corera, Jean-Claude Do Régo & Jean-Jacques Bonnet. 1998. Neurotransmitter Transporters. Neurotransmitter Transporters
203
219
.
Sue L. Povlock & Susan G. Amara. 1997. Neurotransmitter Transporters. Neurotransmitter Transporters
1
28
.
Xiao Xia Tan & Lucio G. Costa. (1995) Long-lasting microencephaly following exposure to cocaine during the brain growth spurt in the rat. Developmental Brain Research 84:2, pages 179-184.
Crossref
Crossref
Cen Xu, Lori L. Coffey & Maarten E.A. Reith. (1995) Translocation of dopamine and binding of 2β-carbomethoxy-3 β-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Biochemical Pharmacology 49:3, pages 339-350.
Crossref
Crossref
Saïda Saadouni, Fatima Refahi-Lyamani, Jean Costentin & Jean-jacques Bonnet. (1994) Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier. European Journal of Pharmacology: Molecular Pharmacology 268:2, pages 187-197.
Crossref
Crossref
Susan M. Meiergerd & James O. Schenk. (2008) Striatal Transporter for Dopamine: Catechol Structure‐Activity Studies and Susceptibility to Chemical Modification. Journal of Neurochemistry 62:3, pages 998-1008.
Crossref
Crossref
Sakire Pogun, Michael H. Baumann & Michael J. Kuhar. (1994) Nitric oxide inhibits [3H]dopamine uptake. Brain Research 641:1, pages 83-91.
Crossref
Crossref
M. M. Schweri. (2004)
Mercuric chloride and
p
‐chloromercuriphenylsulfonate exert a biphasic effect on the binding of the stimulant [
3
H]methylphenidate to the dopamine transporter
. Synapse 16:3, pages 188-194.
Crossref
Crossref
Howard M. Deutsch & Margaret M. Schweri. (1994) Can stimulant binding and dopamine transport be differentiated? Studies with GBR 12783 derivatives. Life Sciences 55:6, pages PL115-PL120.
Crossref
Crossref
Kenneth M. Johnson, John S. Bergmann & Alan P. Kozikowski. (1992) Cocaine and dopamine differentially protect [3H]mazindol binding sites from alkylation by N-ethylmaleimide. European Journal of Pharmacology: Molecular Pharmacology 227:4, pages 411-415.
Crossref
Crossref
Howard M. Deutsch, Margaret M. Schweri, Christopher T. Culbertson & Leon H. Zalkow. (1992) Synthesis and pharmacology of irreversible affinity labels as potential cocaine antagonists: aryl 1,4-dialkylpiperazines related to GBR-12783. European Journal of Pharmacology 220:2-3, pages 173-180.
Crossref
Crossref